Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC26209 | Papain Inhibitor Featured |
#N/A
More description
|
![]() |
DC11230 | JHU-083 Featured |
JHU-083 is a Glutamine antagonist, a DON prodrug.
More description
|
![]() |
DC8050 | Akt Inhibitor IV Featured |
Akt Inhibitor IV is n Inhibitor of Akt protein kinase
More description
|
![]() |
DC8796 | Minodronic acid monohydrate Featured |
![]() |
|
DC24196 | Tri-Salicylic Acid Featured |
![]() |
|
DC10761 | Thiambutosin Featured |
![]() |
|
DC10462 | Broxaldine Featured |
![]() |
|
DC9668 | WAY181187.HCl(WAY-181,187) Featured |
WAY-181187 is a potent and selective 5-HT6 receptor agonist. WAY-181187 possesses high affinity binding (2.2 and 4.8 nM, respectively) at the human 5-HT6 receptor and profile as full receptor agonists (WAY-181187: EC50=6.6 nM, Emax=93%).
More description
|
![]() |
DC10497 | VXc-486 Featured |
VXc-486 is active against drug-resistant isolates, has bactericidal activity, and kills intracellular and dormant M. tuberculosis bacteria in a low-oxygen environment.
More description
|
![]() |
DC12672 | VU6012962 Featured |
VU6012962 (VU-6012962) is a potent, orally bioavailable and CNS penetrant mGlu7 negative allosteric modulator with IC50 of 0.35 uM.
More description
|
![]() |
DC11424 | VCMMAE-(PEG)4-DBCO Featured |
VCMMAE-(PEG)4-DBCO is made by MMAE conjugated to DBCO-(PEG)4-vc-PAB linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate.
More description
|
![]() |
DC10286 | Vaborbactam Featured |
Vaborbactam is a cyclic boronic acid pharmacophore β-lactamase inhibitor.
More description
|
|
DC10084 | UK-371804 HCl Featured |
UK-371804 is a potent and selective uPA inhibitor with excellent enzyme potency (Ki 10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).
More description
|
![]() |
DC10089 | UAMC00039 Featured |
UAMC00039 dihydrochloride is a potent inhibitor of dipeptidyl peptidase II (DPP-II) (IC50 = 0.48 nM).
More description
|
![]() |
DC10696 | U 19963 Featured |
U 19963 is a bioactive compound.
More description
|
![]() |
DC8854 | ARS-853 intermediate Featured |
The intermediate of ARS-853.ARS-853 is a selective, covalent inhibitor of KRAS-G12C that inhibits mutant KRAS driven signaling by binding to the GDP bound oncoprotein and preventing activation.
More description
|
![]() |
DC26077 | EG00229 Featured |
The first small molecule ligand for the VEGF-A receptor neuropilin 1 (NRP1).
More description
|
![]() |
DC7559 | TGF-B (beta) receptor inhibitor Featured |
TGF-β receptor inhibitor
More description
|
![]() |
DC10602 | SU 4313 Featured |
SU 4313 is a bioactive chemical.
More description
|
![]() |
DC26097 | SR-14150 Featured |
SR-14150 is a potent NOP/μ-opioid partial agonist with Ki of 1.39 nM and 29.9 nM, respectively.
More description
|
![]() |
DC26007 | Spastazoline Featured |
Spastazoline is a potent and selective spastin (a microtubule-severing AAA protein) inhibitor, with an IC50 of 99 nM for Human spastin. Spastazoline shows no effect on ATPase activity of a recombinant human VPS4.
More description
|
![]() |
DC8049 | SNG-1153 Featured |
SNG-1153 is a synthetic modulator of ER-α36
More description
|
![]() |
DC6313 | Guadecitabine(SGI-110) Featured |
SGI-110 (S-110) is a stable and potent inhibitor for DNA methylation, inhibits DNMT1 when SGI-110 is activated by phosphorylation and incorporated into DNA.
More description
|
![]() |
DC9924 | SB218078 Featured |
SB218078 is an inhibitor of checkpoint kinase 1 (Chk1) that displays selectivity over other protein kinases (IC50 values are 15, 250 and 1000 nM for Chk1, cdc2 and PKC respectively).
More description
|
![]() |
DC8628 | Saquinavir Mesylate Featured |
Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy.
More description
|
![]() |
DC8627 | Saquinavir Featured |
Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy.
More description
|
![]() |
DC10444 | Sapacitabine (CYC682) Featured |
Sapacitabine is an orally bioavailable pyrimidine analogue prodrug with potential antineoplastic activity.
More description
|
![]() |
DC7948 | PRT-060318(PRT318) Featured |
PRT-060318 is a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in
a transgenic mouse model.
More description
|
![]() |
DC10813 | PRL-8-53 Featured |
PRL-8-53|cas 51352-88-6
More description
|
![]() |
DC12281 | Olutasidenib (FT-2102) Featured |
Olutasidenib is a highly potent, selective inhibitor of mutant Isocitrate dehydrogenase (IDH)1 that could be used in the treatment of acute myeloid leukemia.
More description
|
![]() |